Özet:

Multiple Myelom, which is among the hematological malignities, is a major health problem that negatively affects survival, quality of life, physical, social and psychological condition as a result of the treatments. In the treatment of multiple myeloma patients, treatment options such as chemotherapy, immunomodulating agents and root cell transplant are in combinations. As the first treatment option in patients suitable for root cell transplantation, Lenalidomid is recommended to use an immune-modulating agent and steroid therapy in patients not suitable for birth. Multiple Myelom, hypercalcemia, kidney insufficiency, anemia and bone damage are among the most common symptoms. In the patient's symptom management, it is recommended to monitor the blood calcium levels, treat hypercalcemia, monitor the kidney functions, provide adequate hydration, apply medications according to the kidney dose, monitor and treat anemia, support the diet and avoid physical activities that may cause trauma to patients. It is vital that health professionals follow up-to-date treatment recommendations based on evidence related to the disease and treatment of Multiple Myelom, to prevent symptoms, to improve patient treatment conformity, quality of life and survival. This collection was made with the aim of evaluating current treatment recommendations, symptom management and nursing initiatives in multiple myeloma patients.

Anahtar Kelimeler: